| abstract |
Disclosed are compounds of formula (I) or pharmaceutically acceptable salts or solvates thereof. These compounds are useful for treating chemokine mediated diseases (eg, acute and chronic inflammatory diseases) and cancer. Another aspect of the invention is a pharmaceutical composition containing a compound of formula (I) in combination or association with a pharmaceutically acceptable carrier or diluent. Another aspect of the present invention is a method of treating such a patient in a patient (eg, a mammal (eg, a human)) in need of treating an α-chemokine mediated disease, said method comprising: Includes administering to the patient a therapeutically effective amount of a compound of formula (I), or a pharmaceutically acceptable salt or solvate thereof. |